Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05304962
Title FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Regor Pharmaceuticals Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Hem-Onc Associates of the Treasure Coast ACTIVE_NOT_RECRUITING Port Saint Lucie Florida 34952 United States Details
Emory University RECRUITING Atlanta Georgia 30322 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02142 United States Details
Washington University School of Medicine RECRUITING Saint Louis Missouri 63110 United States Details
New York Cancer and Blood Specialists RECRUITING Port Jefferson Station New York 11776 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field